Article
Osteopontin contributes to late-onset asthma phenotypes in adult asthma patients.
Experimental & molecular medicine - 1 Feb 2020
Trinh Hoang Kim Tu, Nguyen Thuy Van Thao, Kim Seo-Hee, Cao Thi Bich Tra, Luu Quoc Quang, Kim Seung-Hyun, Park Hae-Sim
Abstract excerpt
Patients with late-onset asthma (LOA) have poor clinical outcomes. Osteopontin (OPN) is associated with airway inflammation and remodeling. To investigate the role of OPN in LOA compared to early-onset asthma (EOA), serum OPN levels were compared between 131 adult asthma patients (48 LOA and 83 EOA patients) and 226 healthy controls (HCs). BALB/c mice were sensitized with ovalbumin with/without...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
